The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
Patients experiencing new or worsening skin symptoms should report these to their healthcare provider for appropriate evaluation, as distinguishing between benign reactions and potentially serious hypersensitivity is essential for safe continuation of therapy
100% PURE may earn a small commission for products purchased through affiliate links
Washout strategy (7 to 10 day gap): Administer final Wegovy dose on day 0
You should apply the cream to the intended site about 3060 minutes before your injection
Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice